Cargando…

Editorial: Gone to Pot: Examining the Association Between Cannabis Use and Medical/Psychiatric Disorders

Detalles Bibliográficos
Autores principales:	Radhakrishnan, Rajiv, Guloksuz, Sinan, D'Souza, Deepak C., van Os, Jim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861305/ https://www.ncbi.nlm.nih.gov/pubmed/35211046 http://dx.doi.org/10.3389/fpsyt.2022.837757

Ejemplares similares

Gone to Pot – A Review of the Association between Cannabis and Psychosis
por: Radhakrishnan, Rajiv, et al.
Publicado: (2014)

En attendant Godot: Waiting for the Funeral of “Schizophrenia” and the Baby Shower of the Psychosis Spectrum
por: Guloksuz, Sinan, et al.
Publicado: (2021)

Cannabis and Driving
por: Pearlson, Godfrey D., et al.
Publicado: (2021)

Editorial: Psychological Aspects of Cannabis Use and Cannabis Use Disorder
por: Feingold, Daniel, et al.
Publicado: (2021)

Editorial: Substance use and the psychosis spectrum
por: Kirli, Umut, et al.
Publicado: (2022)

Analysis of GWAS-Derived Schizophrenia Genes for Links to Ischemia-Hypoxia Response of the Brain
por: Schmidt-Kastner, Rainald, et al.
Publicado: (2020)

Estimating Aggregate Environmental Risk Score in Psychiatry: The Exposome Score for Schizophrenia
por: Pries, Lotta-Katrin, et al.
Publicado: (2021)

Genetic and Environmental Influences on the Affective Regulation Network: A Prospective Experience Sampling Analysis
por: Hasmi, Laila, et al.
Publicado: (2018)

Editorial: Psychiatric Disorder in Veterans
por: Pasinetti, Giulio M., et al.
Publicado: (2021)

Editorial: Cognitive Enhancement in Psychiatric Disorders
por: Sumiyoshi, Tomiki, et al.
Publicado: (2019)

Editorial: Neuroinflammation, metabolism, and psychiatric disorders
por: Freyberg, Zachary, et al.
Publicado: (2022)

Editorial: Cardiometabolic disease and psychiatric disorders
por: Deste, Giacomo, et al.
Publicado: (2023)

Editorial: Neurocognitive deficits in psychiatric disorders
por: Yang, Jie
Publicado: (2023)

Editorial: Brain and Somatization Symptoms in Psychiatric Disorders
por: Fu, Xiaoya, et al.
Publicado: (2019)

Editorial: Problematic Gaming, Personality, and Psychiatric Disorders
por: Starcevic, Vladan, et al.
Publicado: (2020)

Editorial: Low-Intensity Interventions for Psychiatric Disorders
por: Sijbrandij, Marit, et al.
Publicado: (2020)

Editorial: Adult ADHD and other psychiatric disorders
por: Oliva, Francesco, et al.
Publicado: (2022)

Editorial: Psychiatric disorders of chronic physical diseases
por: Song, Dan, et al.
Publicado: (2023)

Editorial: Advances in brain dynamics in the healthy and psychiatric disorders
por: Papo, David, et al.
Publicado: (2023)

Editorial: Dual disorders (addictive and concomitant psychiatric disorders): Mechanisms and treatment
por: Vorspan, Florence, et al.
Publicado: (2022)

Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
por: Hindley, Guy, et al.
Publicado: (2020)

Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness
por: Chadwick, Benjamin, et al.
Publicado: (2013)

Editorial: Deconstructing the Influence of Genetic and Age Vulnerability to Psychiatric Disorders
por: Cadoni, Cristina, et al.
Publicado: (2019)

Editorial: Brain and Somatization Symptoms in Psychiatric Disorders, Volume II
por: Fu, Xiaoya, et al.
Publicado: (2022)

Editorial: Clinical practices for co-occurring psychiatric and addictive disorders
por: Picello, Alessio, et al.
Publicado: (2022)

Editorial: Comorbidity in patients with psychiatric disorders: Epidemiological and molecular perspectives
por: Lin, Yezhe, et al.
Publicado: (2023)

Editorial: Clinical application of machine learning methods in psychiatric disorders
por: Liu, Xiaozheng, et al.
Publicado: (2023)

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders
por: Hartelius, Glenn, et al.
Publicado: (2023)

Polysubstance Use in Cannabis Users Referred for Treatment: Drug Use Profiles, Psychiatric Comorbidity and Cannabis-Related Beliefs
por: Connor, Jason P., et al.
Publicado: (2013)

Editorial: Purple Haze: Issues on Cannabis Legalization
por: Potvin, Stéphane, et al.
Publicado: (2021)

Persistency of Cannabis Use Predicts Violence following Acute Psychiatric Discharge
por: Dugré, Jules R., et al.
Publicado: (2017)

Editorial: Computational accounts of reinforcement learning and decision making in psychiatric disorders
por: Chase, Henry W., et al.
Publicado: (2022)

Editorial: Genetic and Epigenetic Mechanisms Underpinning Vulnerability to Developing Psychiatric Disorders
por: Fernández-Castillo, Noèlia, et al.
Publicado: (2022)

Editorial: Somatic comorbidities in psychiatric disorders: From childhood to old age
por: Reininghaus, Eva Z., et al.
Publicado: (2022)

Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis
por: Radhakrishnan, Rajiv, et al.
Publicado: (2023)

Editorial: Cognitive Behavior Therapy and Executive Function in Neurodegenerative Disorders, Psychiatric Disorders, and Injury Research
por: Barron, Jonathan M., et al.
Publicado: (2021)

Editorial: Non-invasive brain stimulation in psychiatric disorders: From bench to bedside
por: Liang, Chih-Sung, et al.
Publicado: (2023)

Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders
por: Blest-Hopley, Grace, et al.
Publicado: (2023)

International perspective on physician knowledge, attitude and practices related to medical cannabis
por: Syed, Shariful A., et al.
Publicado: (2023)

Editorial: Efficacy of Psychological and Psychiatric Treatments and Potential Predictors in Social Anxiety Disorder and Obsessive-Compulsive Disorder
por: Pozza, Andrea
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tp9m089tisuimtn9952dhuhlph